Bio Essence Corporation
BIOE
$0.0937
$0.00272.97%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 129.11% | -645.65% | 97.70% | -456.10% | -261.09% |
| Total Depreciation and Amortization | 0.00% | -66.67% | 200.00% | -66.67% | -40.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -15.94% | -11.54% | -98.73% | 879.94% | 148.40% |
| Change in Net Operating Assets | -41.95% | -61.84% | 33.47% | 210.19% | 325.32% |
| Cash from Operations | 742.91% | -106.17% | 18.48% | 2,233.99% | 108.92% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -76.76% | -- | -- | -3,267.27% | -102.88% |
| Total Debt Repaid | 22.78% | 28.84% | -197.82% | -50,433.33% | 96.91% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 100.00% |
| Cash from Financing | -779.35% | 105.47% | -34.06% | -5,706.90% | -103.38% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 100.00% | 95.10% | -240.89% | 113.68% | -- |